TNF and glioblastoma: This reduction in tumor necrosis factor alpha (TNF‐α), a major regulator of inflammatory responses, may benefit glioblastoma patients by decreasing glutamate release from GBM cells, given the positive correlation between glutamate and TNF‐α (Clark and Vissel 2016).